Details of the Drug Combinations

General Information of This Drug (ID: DMOSQGU)

Drug Name

Nalbuphine DMOSQGU

Synonyms

Intapan; Nalbufina; Nalbuphinum; Intapan (TN); Nalbuphine (INN); Nubain (TN); (5alpha,6alpha)-17-(cyclobutylmethyl)-4,5-epoxymorphinan-3,6,14-triol; 17-cyclobutylmethyl-4,5alpha-epoxymorphinan-3,6alpha,14-triol

Indication

Disease Entry	ICD 11	Status	REF
Pain	MG30-MG3Z	Approved	[1]
Prurigo nodularis	EC91.0	Phase 2/3	[2]
Uremic pruritus	EC90.10	Phase 2/3	[2]
------------------------------------------------------------------------------------

Therapeutic Class

Analgesics

Drug Type

Small molecular drug

Structure

3D MOL

2D MOL

List of Combinatorial Drugs (CBD) Containing This Drug

2 Clinical Trial Drug Combination(s) Consisting of This drug

DrugCom Name	DrugCom ID	Component Drug	Indication	REF
Lidocaine + Nalbuphine	DCQ4S6G	Lidocaine	Conscious Sedation Failure During Procedure	[3]
Lidocaine + Nalbuphine	DCZ6JLT	Lidocaine	Conscious Sedation Failure During Procedure	[3]
------------------------------------------------------------------------------------

References

1	URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1663).
2	Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
3	ClinicalTrials.gov (NCT02820051) Non-anesthesiologist-administered Propofol During the Flexible Bronchoscopy